All News #Library
Biotech
Gan & Lee Starts Ph 3 Trial For 1st Chinese Monthly GLP-1 RA
27 Nov 2025 //
PR NEWSWIRE
Gan & Lee Pharma: First Participant Dosed in US Study for Obesity
10 Mar 2025 //
PR NEWSWIRE
Gan & Lee Pharma Receives FDA Clearance for Bofanglutide IND
18 Dec 2024 //
PR NEWSWIRE
Gan & Lee Pharma Announces Positive Ph 1 Results for GZR18 Tablet
12 Nov 2024 //
PR NEWSWIRE
Chinese insulin maker’s GLP-1 bests Ozempic in ph. 2, company says
15 Oct 2024 //
FIERCE BIOTECH
Gan & Lee Announces Progress on Diabetes and Obesity Treatments at ADA 84th
22 Jun 2024 //
PR NEWSWIRE

Market Place
Sourcing Support